AlphaYou5P
Schedule 13D filing
5AM Partners VII, LLC disclosed a 26.1% stake in Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC reported owning 26.1% of Skye Bioscience, Inc. (SKYE) (1,218,088 shares) in a Schedule 13D filed Sep 24, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 24, 2026
- Source
- Schedule 13D
More SKYE insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.